SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-093567
Filing Date
2024-11-01
Accepted
2024-11-01 17:00:20
Documents
15
Period of Report
2024-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0219546-8k_osthera.htm   iXBRL 8-K 38098
2 EQUITY PURCHASE AGREEMENT, DATED AS OF OCTOBER 31, 2024, BETWEEN OS THERAPIES IN ea021954601ex10-1_osthera.htm EX-10.1 199597
3 REGISTRATION RIGHTS AGREEMENT, DATED OCTOBER 31, 2024 ea021954601ex10-2_osthera.htm EX-10.2 85060
  Complete submission text file 0001213900-24-093567.txt   575831

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ostx-20241031.xsd EX-101.SCH 3024
5 XBRL LABEL FILE ostx-20241031_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ostx-20241031_pre.xml EX-101.PRE 22365
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0219546-8k_osthera_htm.xml XML 3811
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

IRS No.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42195 | Film No.: 241419859
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)